Jaleva Pharmaceuticals, a specialty pharma company, develops dermal drug delivery systems for CNS markets, based in San Diego.
Jaleva Pharmaceuticals, LLC is a specialty pharmaceutical company focused on developing innovative dermal drug delivery systems for central nervous system (CNS) markets. Based in San Diego, the company offers products such as Mast-R-Prep, a chlorhexidine-based surgical skin prep, and Stayzon, an antibiotic surgical adhesive. Their formulations aim to enhance the delivery of medications like alprazolam for anxiety, ondansetron for nausea, and sumitriptan for migraines through transmucosal and topical methods.
Jaleva Pharmaceuticals has made significant strides in the CNS pharmaceutical market by creating effective and user-friendly drug delivery systems. Their products are designed to improve patient outcomes by providing more efficient medication administration. The company's focus on research and development has positioned it as a key player in the specialty pharma sector, contributing to advancements in surgical preparations and CNS treatments.

Skinvisible
skinvisible.com
SkinJect
skinjectpatch.com
Ivrea Pharmaceuticals
NovaDel Pharma
Transport Pharmaceuticals

Impel Pharmaceuticals
impelpharma.com

Azevan Pharmaceuticals
azevan.com

Aquestive Therapeutics
aquestive.com

Alltranz
alltranz.com.au
Novelix Pharmaceuticals

Trilogic Pharma
trilogicpharma.com

Fidelis Pharmaceuticals
fidelisrx.com

Jazz Pharmaceuticals
jazzpharma.com

Vascarta
vascarta.com

Tris Pharma
trispharma.com

Microdermis
microdermis.com

Strategic Science & Technologies

QuVa Pharma
onequva.com

Mojave Pharma
Abrexa Pharmaceuticals
Jaleva Pharmaceuticals' most recent funding round was for $454.5k (USD) in May 2011.
As of May 31, 2011, Jaleva Pharmaceuticals has disclosed funding of $454.5k (USD).